Episode titled "From Medicine to Biotech Innovation" now availablePITTSBURGH, March 31, 2025 (GLOBE NEWSWIRE) -- Lipella ...

Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.

With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.

ROURKELA: Researchers of the biotechnology and medical engineering wing of the National Institute of Technology-Rourkela (NIT ...

Q4 2024 Earnings Call Transcript March 27, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is ...

Alector said Gary Romano is stepping down as medical chief after about three years in the role, and will be replaced by Giacomo Salvadore. The late-stage clinical biotechnology company with a focus on ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

The hub will evaluate how emerging therapeutics, including GLP-1 agonists, might impact cancer progression and treatment.

Multinational pharmaceutical firms, particularly U.S. giants, are increasingly recognizing China's burgeoning innovative drug sector as a strategic goldmine to bolster their global competitiveness.

AbbVie, Danaher, Thermo Fisher Scientific, Cognizant Technology Solutions, Vertex Pharmaceuticals, Alnylam Pharmaceuticals, ...